Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial

Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in... J Endocrinol Invest (2018) 41:475–483 https://doi.org/10.1007/s40618-017-0786-8 ORIGINAL ARTICLE Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial 1 2 3 4 5 6 7 J. Kim  · B.‑K. Suh  · C. W. Ko  · K.‑H. Lee  · C. H. Shin  · J. S. Hwang  · H. S. Kim  · 8 9 10 11 1 12 W. Y. Chung  · C. J. Kim  · H.‑S. Han  · N. Y. Kwon  · S. Y. Cho  · H.‑W. Yoo  · D.‑K. Jin   Received: 13 July 2017 / Accepted: 25 October 2017 / Published online: 4 November 2017 © The Author(s) 2017. This article is an open access publication Abstract 0.63 ± 0.16 and 0.64 ± 0.46, respectively, for the treatment Purpose Several studies have evaluated the effects of group, and 0.06 ± 0.15 and 0.06 ± 0.28, respectively, for the growth hormone (GH) on auxological and biochemical control group (p < 0.001). Serum insulin-like growth fac- parameters in children with non-GH-deficient, idiopathic tor (IGF-1) and insulin-like growth factor binding protein-3 short stature (ISS). This study evaluated the efficacy and (IGFBP-3) increased significantly in the treatment group at safety of Gr owtropin -II (recombinant human GH) in week 26 compared to baseline. However, the SDS for body Korean patients with ISS. mass index (BMI) at 26 weeks did not change significantly Methods This was a 1-year, open-label, multicenter, phase in either http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Endocrinological Investigation Springer Journals

Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial

Loading next page...
 
/lp/springer_journal/recombinant-growth-hormone-therapy-for-prepubertal-children-with-bHcpEE8SYw
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Medicine/Public Health, general; Endocrinology; Metabolic Diseases
eISSN
1720-8386
D.O.I.
10.1007/s40618-017-0786-8
Publisher site
See Article on Publisher Site

Abstract

J Endocrinol Invest (2018) 41:475–483 https://doi.org/10.1007/s40618-017-0786-8 ORIGINAL ARTICLE Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial 1 2 3 4 5 6 7 J. Kim  · B.‑K. Suh  · C. W. Ko  · K.‑H. Lee  · C. H. Shin  · J. S. Hwang  · H. S. Kim  · 8 9 10 11 1 12 W. Y. Chung  · C. J. Kim  · H.‑S. Han  · N. Y. Kwon  · S. Y. Cho  · H.‑W. Yoo  · D.‑K. Jin   Received: 13 July 2017 / Accepted: 25 October 2017 / Published online: 4 November 2017 © The Author(s) 2017. This article is an open access publication Abstract 0.63 ± 0.16 and 0.64 ± 0.46, respectively, for the treatment Purpose Several studies have evaluated the effects of group, and 0.06 ± 0.15 and 0.06 ± 0.28, respectively, for the growth hormone (GH) on auxological and biochemical control group (p < 0.001). Serum insulin-like growth fac- parameters in children with non-GH-deficient, idiopathic tor (IGF-1) and insulin-like growth factor binding protein-3 short stature (ISS). This study evaluated the efficacy and (IGFBP-3) increased significantly in the treatment group at safety of Gr owtropin -II (recombinant human GH) in week 26 compared to baseline. However, the SDS for body Korean patients with ISS. mass index (BMI) at 26 weeks did not change significantly Methods This was a 1-year, open-label, multicenter, phase in either

Journal

Journal of Endocrinological InvestigationSpringer Journals

Published: Nov 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial